89 H. Aarsetøy et al., “Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction.”
90 R. Marchioli et al., “Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione.”
91 C. M. Albert et al., “Blood levels of long-chain n-3 fatty acids and the risk of sudden death.”
92 G. P. Amminger et al., “Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.”
93 E. C. Rizos et al., “Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.”
94 Q. Chen et al., “Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.”
95 M. C. Morris et al., “Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.”
96 E. J. Schaefer et al., “Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.”
97 P. Barberger-Gateau et al., “Dietary patterns and risk of dementia: the Three-City cohort study.”
98 H. M. Krumholz et al., “Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.”